Open AccessEfficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection
Author(s) -
Antoine Bachelard,
Valentina Isernia,
D. Vallois,
Sylvie Le Gac,
Lynda Chalal,
Roland Landman,
Florence Damond,
Diane Descamps,
Yazdan Yazdanpanah,
Gilles Peytavin,
Jade Ghosn
Publication year - 2021
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkab192
Subject(s) - emtricitabine , tolerability , medicine , tenofovir alafenamide , human immunodeficiency virus (hiv) , virology , tenofovir , antiretroviral therapy , viral load , adverse effect
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom